7 medical IPOs approved in H1

Tighter review process slowing approvals for public offerings

A total of 360 healthcare enterprises in the Chinese mainland have seen their IPO plans approved to date, with seven more companies joining the list in the first half of 2018, a slight deceleration, according to a report.

Among the seven enterprises, four were listed on the mainland's A-share market. The remaining three were listed on the Hong Kong Stock Exchange.